SenesTech (NASDAQ: SNES), the inventor of ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve(R) and Evolve Mouse(R), EPA-designated minimum risk contraceptives for rodents, recently reported financial results for its second quarter of fiscal 2024, ended June 30, 2024. In addition, Joel Fruendt, President and CEO of SenesTech, and […]

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, announced positive results of two independently conducted Phase 2 clinical trials, RESCUE-ALS and HEALEY ALS Platform Trials, of CNM-Au8 for the treatment of amyotrophic lateral sclerosis (“ALS”) (https://ibn.fm/ktu4u). The new CNM-Au8 biomarker and clinical […]

The National Investment Banking Association (“NIBA”) invites the micro-cap and small-cap investment community to its 150th investment conference. The event will be held on September 4-5, 2024, at the Westin Fort Lauderdale Beach Resort, Ft. Lauderdale, Florida. Since 1982, The National Investment Banking Association has been a not-for-profit association for the micro-cap and small-cap investment […]

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, released its second quarter 2024 financial results along with recent business and technical updates. The company reported growth in key areas, reflecting its continued momentum in the quantum computing market (https://ibn.fm/DNZ11). D-Wave has made […]

Sprout Social (NASDAQ: SPT), a frontrunner in cloud-based social media management software, recently made headlines with the appointment of Mike Wolff as its new Chief Revenue Officer. This strategic move is aimed at bolstering Sprout Social’s global sales, success, and partnerships organization, with a keen focus on accelerating the company’s worldwide growth and expansion. Wolff’s […]

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, presented significant data and findings of its Phase 2/3 Alzheimer’s study of lead drug candidate buntanetap at the Alzheimer’s Association International Conference(R) 2024 (AAIC(R)) in Philadelphia. Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of the company detailed these […]

In 2023, it was estimated that New York City had roughly 3 million rats, an increase of almost 1 million over the last ten years. The situation has gotten so bad that the city has become almost synonymous with rat infestation problems. This statistic paints an astonishing picture of the rodent problem in the U.S., […]

A surge in exports in June confounded pundits that called for Canada to experience a fourth straight monthly trade shortfall. Canada unexpectedly posted a C$638 million trade surplus in June, driven primarily by increased crude oil shipments facilitated by the expanded Trans Mountain pipeline and a surge in gold exports. Canada’s recent export data is […]

In a 2023 study, Coresight Research surveyed decision makers at U.S.-based apparel brands and retailers, revealing that the average return rate of online apparel orders in the U.S. stood at an estimated 24.4%. This return rate translated to $38 billion in returns – based on the research firm’s estimate of the value of the online […]

Connect with the leaders and social media marketing heads from leading colleges and universities at the Social Media Strategies Summit for Higher Education 2024. Attractive early bird offers are available. The tickets include access to the Higher Ed Summit on October 21–22, 2024, and the Corporate Brand Summit on October 24–25. The workshops are optional […]